ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 960 filers reported holding ASTRAZENECA PLC in Q3 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $491,337 | +386.4% | 6,300 | +320.0% | 0.01% | +700.0% |
Q4 2023 | $101,025 | -99.4% | 1,500 | -99.4% | 0.00% | -99.6% |
Q3 2023 | $16,320,520 | -45.6% | 241,000 | -42.5% | 0.25% | -52.5% |
Q2 2023 | $29,982,176 | +15.0% | 418,921 | +11.6% | 0.53% | +5.6% |
Q1 2023 | $26,063,455 | -9.1% | 375,500 | -11.2% | 0.50% | +12.3% |
Q4 2022 | $28,679,400 | +12.1% | 423,000 | -9.3% | 0.45% | +26.9% |
Q3 2022 | $25,580,000 | +230.9% | 466,465 | +298.7% | 0.35% | +229.9% |
Q2 2022 | $7,731,000 | +2235.6% | 117,000 | +2240.0% | 0.11% | +2575.0% |
Q1 2022 | $331,000 | -99.2% | 5,000 | -99.3% | 0.00% | -99.2% |
Q4 2021 | $43,578,000 | -30.8% | 748,100 | -28.7% | 0.49% | -32.2% |
Q3 2021 | $63,010,000 | +56.6% | 1,049,112 | +56.2% | 0.72% | +37.6% |
Q2 2021 | $40,237,000 | +229.3% | 671,700 | +173.3% | 0.52% | +99.2% |
Q1 2021 | $12,219,000 | +258.9% | 245,759 | +260.9% | 0.26% | +237.2% |
Q4 2020 | $3,405,000 | -86.3% | 68,100 | -85.5% | 0.08% | -90.5% |
Q2 2020 | $24,765,000 | – | 468,250 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |